Striking senescence with sodium transporter inhibition
- PMID: 39004548
- DOI: 10.1016/j.molmed.2024.07.002
Striking senescence with sodium transporter inhibition
Abstract
Senescence is associated with multiple morbidities and therapeutic targeting of these cells is a key aim. In a recent study, Katsuumi et al. found that targeting sodium-glucose co-transporter 2 (SGLT2) promoted immune clearance of senescent cells via programmed cell death-1 ligand (PD-L1) suppression, thus promoting immunosurveillance. This could have profound implications for many age-related diseases, including cancer and frailty.
Keywords: AMPK; age-related diseases; immunosurveillance; senescence; senolysis.
Copyright © 2024 Elsevier Ltd. All rights reserved.
Conflict of interest statement
Declaration of interests The authors declare no conflicts of interest.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials